|
🐜
|
SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
43 auth.
J. Qiao,
Yue-Shan Li,
R. Zeng,
Feng-Liang Liu,
Rong-Hua Luo,
Chong Huang,
Yi-Fei Wang,
Jie Zhang,
B. Quan,
Chenjian Shen,
X. Mao,
Xinlei Liu,
Weining Sun,
Wei Yang,
X. Ni,
...
Kai Wang,
Ling Xu,
Zilei Duan,
Qing-Cui Zou,
Hai-Lin Zhang,
Wang Qu,
Yang-Hao-Peng Long,
Ming-hua Li,
Rui Yang,
Xiaolong Liu,
Jing You,
Yangli Zhou,
R. Yao,
Wen-Pei Li,
Jingming Liu,
Pei Chen,
Yang Liu,
Guifeng Lin,
Xin Yang,
Jun Zou,
Linli Li,
Yiguo Hu,
G. Lu,
Weiming Li,
Yuquan Wei,
Yong-tang Zheng,
Jiankun Lei,
Sheng-yong Yang
|
8 |
2021 |
8
🐜
|
|
🐜
|
SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model
43 auth.
J. Qiao,
Yue-Shan Li,
R. Zeng,
Feng-Liang Liu,
Rong-Hua Luo,
Chong Huang,
Yi-Fei Wang,
Jie Zhang,
B. Quan,
Chenjian Shen,
X. Mao,
Xinlei Liu,
Weining Sun,
Wei Yang,
X. Ni,
...
Kai Wang,
Ling Xu,
Zilei Duan,
Qing-Cui Zou,
Hai-Lin Zhang,
Wang Qu,
Yang Long,
Ming-hua Li,
Rui Yang,
Xiaolong Liu,
Jing You,
Yangli Zhou,
R. Yao,
Wen-Pei Li,
Jingming Liu,
Pei Chen,
Yang Liu,
Guifeng Lin,
Xin Yang,
Jun Zou,
Linli Li,
Yiguo Hu,
G. Lu,
Weiming Li,
Yuquan Wei,
Yong-tang Zheng,
Jiankun Lei,
Sheng-yong Yang
|
6 |
2021 |
6
🐜
|
|
🐜
|
Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
12 auth.
Jianxiong Zeng,
Xiaochun Xie,
Xiao-li Feng,
Ling Xu,
Jian-bao Han,
Dandan Yu,
...
Qing-Cui Zou,
Qianjin Liu,
Xiaohong Li,
Guanqin Ma,
Mingha Li,
Yong-Gang Yao
|
6 |
2021 |
6
🐜
|
|
🐜
|
Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1
12 auth.
Yujun Li,
Haimin Wang,
Xiaojuan Tang,
Danting Ma,
Chengzhi Du,
Yifei Wang,
...
Hong Pan,
Qing-Cui Zou,
Jie Zheng,
Liangde Xu,
M. Farzan,
Guocai Zhong
|
5 |
2020 |
5
🐜
|
|
🐜
|
Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies
8 auth.
Xiaochun Xie,
Jian-bao Han,
Guanqin Ma,
Xiao-li Feng,
Xiaohong Li,
Qing-Cui Zou,
...
Zhong-Hua Deng,
Jianxiong Zeng
|
4 |
2021 |
4
🐜
|
|
🐜
|
SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathy
15 auth.
Guanqin Ma,
Deng-Feng Zhang,
Qing-Cui Zou,
Xiaochun Xie,
Ling Xu,
Xiao-li Feng,
Xiaohong Li,
Jian-bao Han,
Dandan Yu,
Zhong-Hua Deng,
...
Wang Qu,
J. Long,
Mingha Li,
Yong-Gang Yao,
Jianxiong Zeng
|
4 |
2022 |
4
🐜
|
|
🐜
|
Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA
15 auth.
Yuan Liu,
L. Dai,
Xiao-li Feng,
Ran Gao,
N. Zhang,
Bin Wang,
Jian-bao Han,
Qing-Cui Zou,
Xi-ling Guo,
Hua Zhu,
...
Jiangning Liu,
Chuan Qin,
Yi Zhang,
L. Bao,
Minghua Li
|
3 |
2021 |
3
🐜
|
|
🐜
|
Relationship between SARS-CoV-2 nucleocapsid protein and N gene and its application in antigen testing kits evaluation
12 auth.
Tao Peng,
Lianhua Dong,
Xiaoli Feng,
Yi Yang,
Xia Wang,
Chunyan Niu,
...
Zhan-Hang Liang,
Wang Qu,
Qing-Cui Zou,
Xinhua Dai,
Minghua Li,
Xiang Fang
|
2 |
2023 |
2
🐜
|
|
🐜
|
Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates
18 auth.
Xiao-li Feng,
Dandan Yu,
Mi Zhang,
Xiaohong Li,
Qing-Cui Zou,
Wentai Ma,
Jian-bao Han,
Ling Xu,
Cuixian Yang,
Wang Qu,
...
Zhong-Hua Deng,
J. Long,
Yanghaopeng Long,
Mingkun Li,
Y. Yao,
Xingqi Dong,
Jianxiong Zeng,
Mingha Li
|
2 |
2022 |
2
🐜
|
